Pedagogically, the work concentrates on the latest knowledge, laboratory techniques, and experimental approaches used by translational research leaders in this field, promoting a cross-disciplinary communication between the sub-specialities of medicine, but in common with other books on the topic. In addition, the book emphasizes recent innovations, critical barriers to progress, the new tools that are being used to overcome them, and specific areas of research that require additional study to advance the field as a whole.
- Encompasses the latest innovations and tools being used to apply microRNA from lab to clinic<- Extensive pedagogical updates aiming to improve the education of translational researchers in this field- Transdisciplinary approach aims to support cross-fertilization between different sub-specialties of medicine
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
2. MicroRNA targets for cancer therapy (Carlo Croce, MD)
3. MicroRNAs as Targets for Lung Cancer Therapy and Prevention (Ethan Dmitrovsky, M.D.)
4. MicroRNAs as biomarkers in lung cancer: miracle or quagmire? (Robert Kratzke, MD)
5. MicroRNAs in inflammatory lung disease (Joe GN Garcia MD)
6. MicroRNAs and lung fibrosis (Naftali Kaminski MD)
7. MicroRNAs and diabetes (Romano Regazzi, PhD)
8. MicroRNAs and liver disease (Nicholas O. Davidson, MD; Kevin Korenblat, MD; Tom Kerr, MD, PhD)
9. MicroRNAs and cardiovascular disease (Gerald Dorn, MD)
10. MicroRNAs and diabetic nephropathy and vascular disease in kidney tissue (Bryan Becker, MD)
11. MicroRNAs and autoimmunity (Ansar Ahmed, DVM, PhD)
12. MicroRNAs and neurodegenerative diseases (Edgardo Rodriguez-Lebron, PhD)
13. MicroRNAs in viral hepatitis (TBA)
Dr Laurence is pursuing the pathophysiology of cardiovascular and skeletal abnormalities linked to HIV disease and its therapies at Weill Cornell. Dr Laurence is the editor-in-chief of Translational Medicine, which Elsevier co-publishes with the CSCTR.